Follow our live coverage from the 36th Oncology Nursing Society Annual Congress in Boston.


Patient/family teaching sessions "personalizes" the radiation therapy experience

Joyce Pagan April 30, 2011

An educational class developed and implemented to help prepare patients and families for their radiation therapy treatment experience has been well received overall by the 128 participants who have completed the sessions thus far, according to a presentation reported during the Oncology Nursing Society 36th Annual Congress.
 

Skin care protocol and algorithm helps manage skin reactions in oncology patients undergoing radiation therapy

Joyce Pagan April 30, 2011

Skin reactions, common side effects of cancer radiation treatment, can be managed using a skin care protocol and algorithm, according to a presentation at the Oncology Nursing Society 36th Annual Congress.
 

Animal-assisted therapy program helps radiation therapy outpatients decrease anxiety

Joyce Pagan April 30, 2011

The radiation oncology department at Duke University Medical Center, Durham, North Carolina, has instituted an animal-assisted therapy (AAT) program to help outpatients reduce stress, improve mood, and decrease anxiety during their radiation therapy visit, according to a presentation during the Oncology Nursing Society 36th Annual Congress.
 

Managing viral infections in severely immunocompromised patients

Debra Hughes April 30, 2011

Oncology nurses play a vital role in patient care, including assessment, early recognition of infections, and patient and family education. Providing evidence-based care and education to severely immunocompromised patients requires knowledge about the association between viruses and diseases, the rationale of specific diagnostic tests, and current treatments.
 

Oncology FBI team helps promote a culture of safety

Debra Hughes April 30, 2011

Monitoring infection rates and introducing interventions to eliminate central line-associated bloodstream infections (CLABSIs), a serious safety concern for hospitalized oncology patients, is one way nursing care can be advanced in complex health care environments that support a culture of safety, according to a presentation at the Oncology Nursing Society 36th Annual Congress.
 

"Distress thermometer" screening tool can improve outcomes in patients with pancreatic cancer

Debra Hughes April 30, 2011

Patients with pancreatic cancer frequently experience high levels of anxiety and distress, in part because the disease carries a poor prognosis, necessitating frequent clinic visits. To help identify and characterize patient distress, the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, has utilized a distress thermometer (DT) screening tool at each clinic visit since 2005, according to a presentation at the Oncology Nursing Society 36th Annual Congress.
 

Documenting chemotherapy administration assures patients safety

Traci Dantoni April 30, 2011

Safe administration of chemotherapy and compliance with hospital policy and regulatory guidelines require a specific verification process that must be documented as part of the patient record when administering chemotherapy, according to research presented at the Oncology Nursing Society 36th Annual Congress.
 

Changing practice behaviors reduces central line-associated bloodstream infections

Traci Dantoni April 30, 2011

The effects of cancer treatment place patients at high risk for central line-associated blood stream infections (CLABSIs), which directly reflect the care provided at the time of insertion and through the lifetime of the central line. These infections are a significant cause of morbidity, mortality, and increased health care costs. These are the findings of a study presented at the Oncology Nursing Society 36th Annual Congress.
 

Nilotinib provides durable responses in patients with newly diagnosed chronic myeloid leukemia in chronic phase

Debra Hughes April 30, 2011

Results of an 18-month evaluation in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) presented during the Oncology Nursing Society 36th Annual Congress continue to confirm the superior efficacy of nilotinib to imatinib. Although imatinib has long been considered the standard of care for the frontline treatment of CML-CP, clinical evidence shows some patients have inadequate response, develop resistance, or develop intolerable side effects.
 

Nurses in ideal position to deliver messages that increase HPV vaccine acceptability

Joyce Pagan April 30, 2011

Nurses should be aware of a stigma surrounding human papillomavirus (HPV) vaccination and factor that into communications with patients, Cheryl S. Lee, MS, RN, ACNP-BC, MD Anderson Cancer Center, Houston, Texas, said in presenting a systematic review of how messages about the HPV vaccine are framed during the Oncology Nursing Society 36th Annual Congress.
 

ONS 2011 Video
Interview with Crista Creedle, RN, BSN, OCN and Ashley Leak, BSN, MSN: Play

Interview with Lori D'Ambrosio, MBA, BSN, RN, OCN: Play

Interview with Amy Rettig, MSN, MALM, RN, ACNS-BC, CBCN: Play

Interview with Brenda Shelton, MS, RN, CCRN, AOCN: Play


Web Exclusives

Side effects of certain cancer drugs may be fatal

February 22, 2012

Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
 

High-definition blood test may become comparable to biopsy

February 21, 2012

An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
 

Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy

February 20, 2012

A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions